Brigham & Women's Hospital — Boston, Massachusetts

Public research footprint of Brigham & Women's Hospital, compiled from the ClinicalTrials.gov public registry.

346

Registered studies

Active

Recruiting now

214

Completed

Stopped or withdrawn

Most-studied conditions

Cystic Fibrosis Pulmonary Exacerbation · Rheumatoid Arthritis (RA) · Squamous Cell Carcinoma of Head and Neck · High-Risk Percutaneous Coronary Intervention (High-risk PCI)

Recently updated registry entries

NCT06885177 — TECTONIC CAD IVL IDE Study (Active Not Recruiting)
NCT05021835 — ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People… (Completed)
NCT03975647 — A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1)… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Brigham & Women's Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.